Zdzisława Kycler

Zdzisława Kycler

Auto-generated profile, based on publicly available information

Zdzisława Kycler

Department of Pediatric Pneumonology, Allergology and Clinical Immunology, Institute of Pediatrics Poznan University of Medical Sciences Poznan Poland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
Aleksandra Szczawińska-PopłonykAleksandra Szczawińska-Popłonyk
Aleksandra Szczawińska-Popłonyk
ZKZdzislawa Kycler
Zdzislawa Kycler
BPBarbara Pietrucha
Barbara Pietrucha
EHEdyta Heropolitanska-Pliszka
Edyta Heropolitanska-Pliszka
JMJan Matysiak
Jan Matysiak
Karolina GerrethKarolina Gerreth
Karolina Gerreth
The hyper-IgE syndromes are rare, complex primary immunodeficiencies characterized by clinical manifestation diversity, by particular susceptibility to staphylococcal and mycotic infections as well as by a heterogeneous genetic origin. Two distinct entities - the classical hyper-IgE syndrome which is inherited in an autosomal dominant pattern and the autosomal recessive hyper-IgE syndrome have been recognized. The autosomal dominant hyper-IgE syndrome is associated with a cluster of facial, dental, skeletal, and connective tissue abnormalities which are not observable in the recessive type. In the majority of affected patients with autosomal dominant hyper-IgE syndrome a mutation in the signal transducer and the activator of the transcription 3 gene has been identified, leading to an impaired Th17 cells differentiation and to a downregulation of an antimicrobial response. A mutation in the dedicator of the cytokinesis 8 gene has been identified as the cause of many cases with autosomal recessive hyper-IgE syndrome and, in one patient, a mutation in tyrosine kinase 2 gene has been demonstrated. In this paper, the authors provide a review of the clinical manifestations in the hyper-IgE syndromes with particular emphasis on the diversity of their phenotypic expression and present current diagnostic guidelines for these diseases.

1 January 2013 in Respiratory Medicine
Verified
Journal Article
Closed access
ASAleksandra Szczepankiewicz
Aleksandra Szczepankiewicz
Marta RachelMarta Rachel
Marta Rachel
PSPaulina Sobkowiak
Paulina Sobkowiak
ZKZdzisława Kycler
Zdzisława Kycler
IBIrena Wojsyk – Banaszak
Irena Wojsyk – Banaszak
ABAnna Bręborowicz
Anna Bręborowicz

Verified
Journal Article
Open access
PDF file
ZSZuzanna Stachowiak
Zuzanna Stachowiak
IBIrena Wojsyk – Banaszak
Irena Wojsyk – Banaszak
KJKatarzyna Jonczyk-Potoczna
Katarzyna Jonczyk-Potoczna
BNBeata Narożna
Beata Narożna
WLWojciech Langwiński
Wojciech Langwiński
Aleksandra SzczepankiewiczAleksandra Szczepankiewicz
Aleksandra Szczepankiewicz
MicroRNAs are small non-coding RNAs that regulate immune response and inflammation. We assumed that miRNAs may be involved in the immune response during cystic fibrosis pulmonary exacerbations (CFPE) and that altered expression profile in the airways and blood may underlie clinical outcomes in CF pediatric patients. Methods: We included 30 pediatric patients diagnosed with cystic fibrosis. The biologic material (blood, sputum, exhaled breath condensate) was collected during pulmonary exacerbation and in stable condition. The miRNA expression profile from blood and sputum (n = 6) was done using the next-generation sequencing. For validation, selected four miRNAs were analyzed by qPCR in exosomes from sputum supernatant and exhaled breath condensate (n = 24). NGS analysis was done in Base Space, correlations of gene expression with clinical data were done in Statistica. Results: The miRNA profiling showed that four miRNAs (miR-223, miR-451a, miR-27b-3p, miR-486-5p) were significantly altered during pulmonary exacerbation in CF patients in sputum but did not differ significantly in blood. MiRNA differently expressed in exhaled breath condensate (EBC) and sputum showed correlation with clinical parameters in CFPE. Conclusion: MiRNA expression profile changes in the airways during pulmonary exacerbation in CF pediatric patients. We suggest that miRNA alterations during CFPE are restricted to the airways and strongly correlate with clinical outcome.

1 January 2012 in Archives of Medical Science
Verified
Journal Article
Open access
ECEwa Cichocka-Jarosz
Ewa Cichocka-Jarosz
PBPiotr Brzyski
Piotr Brzyski
EŚEwa Świebocka
Ewa Świebocka
JLJoanna Lange
Joanna Lange
BTBeata Tobiasz-Adamczyk
Beata Tobiasz-Adamczyk
JPJacek J. Pietrzyk
Jacek J. Pietrzyk
Introduction: Venom allergy, though rare, may seriously influence health-related quality of life (HRQoL). There is a paucity of research on HRQoL of adolescents and young adults with Hymenoptera venom allergy. The aim was to assess the level of HRQoL and to evaluate its independent predictors...

31 March 2012 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
ASAleksandra Szczepankiewicz
Aleksandra Szczepankiewicz
Marta RachelMarta Rachel
Marta Rachel
PSP. Sobkowiak
P. Sobkowiak
ZKZ. Kycler
Z. Kycler
IBIrena Wojsyk – Banaszak
Irena Wojsyk – Banaszak
ABA. Bręborowicz
A. Bręborowicz

3 April 2012 in Journal of Asthma
Verified
Journal Article
Closed access
ASAleksandra Szczepankiewicz
Aleksandra Szczepankiewicz
PSPaulina Sobkowiak
Paulina Sobkowiak
Marta RachelMarta Rachel
Marta Rachel
ABAnna Bręborowicz
Anna Bręborowicz
NSNatalia Schoneich
Natalia Schoneich
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
Objectives. Asthma is a heterogenous complex disorder caused by chronic inflammation of the airways. The key issue in genetic association studies of complex disorders is the identification of multiple low-risk genes that individually have little impact on the phenotype, but in combination account for the clinical manifestation of asthma. Since neurogenic inflammation is emerging as a candidate factor in the pathogenesis of asthma, the aim of the study was to investigate whether genetic variants of neurotrophin genes are associated with asthma disease severity or asthma-related phenotypes in a pediatric population. Methods. We genotyped 27 polymorphisms located in neurotrophin genes, using TaqMan SNP genotyping assays or Polymerase Chain Reaction - Restriction Fragments Lengths Polymorphism (PCR-RFLP) in 200 children diagnosed with asthma and 226 controls. Interactions between 27 polymorphic loci and asthma-related phenotypes were determined using the Multifactor Dimensionality Reduction (MDR) method. Results. In single marker analysis, we observed an association of MAP3K1 gene polymorphisms (rs702689 and rs889312) with asthma. We also observed that four Single Nucleotide Polymorphisms (SNPs) were associated with severe asthma. Analysis stratified by asthma-related phenotype revealed an association between atopy and NGFR (rs3785931), while BDNF (rs7124442), NTRK2 (rs1212171), NGFR (rs2072446), and FYN (rs3730353) variants were associated with increased exhaled nitric oxide (exNO). In addition, gene–gene interaction analysis revealed a significant epistatic interaction between MAPK (rs889312) and NGF (rs11102930) variants in asthma susceptibility. Conclusions. Our results suggest that genetic variants of MAP3K1 and NGF genes involved in the regulation of neurogenic inflammation may contribute to asthma, possibly via enhanced NGF expression and MAPK signaling pathway activation.